If you are developing a biosimilar, validating a biomarker, monitoring therapeutic drug levels, or conducting translational research, one thing remains constant - your results are only as reliable as the…
Most conversations about biosimilar analytical development focus on pharmacokinetics and immunogenicity, and for good reason. Both are central to demonstrating comparability. But a QC package is not complete without two…
Most updates about production milestones sound like success stories written after the fact, once everything already works. This one is written closer to the middle of the process, because that…
When you ask most people, why so few companies in India develop antigens and antibodies indigenously, the assumption is usually about raw material access. This is not actually the constraint.The…
Rituximab Biosimilar PK Monitoring Most conversations about biosimilar PK monitoring treat the molecule as the starting point. Identify the drug. Select an assay validated for that drug. Run the study.…
Why the Assay design starts with the molecule? Most biosimilar PK monitoring conversations in India focus on monoclonal antibodies. Adalimumab, Rituximab, Bevacizumab. These are the molecules with the largest development…
When the Government of India announced Biopharma SHAKTI in the Union Budget 2026 - a ₹10,000 crore national investment to strengthen India's biologics and biosimilars manufacturing ecosystem - it was…
Scale-up is the moment a biosimilar program starts feeling real. Moving from a 10L bench-scale fermentation to a 200L pilot run is a tangible sign that the program is progressing.…
Bevacizumab Biosimilar Development Bevacizumab is one of the more commercially significant biologics in India's biosimilar pipeline right now. Several companies are at different stages of development for oncology and ophthalmology…
Insights from recent customer interactions with leading pharmaceutical manufacturersIntroductionThis week, we had conversations with QC and R&D leadership from leading biopharma companies across India.The conversation wasn't about marketing our products.…
Inside our exclusive roadshow at one of India's premier drug discovery institutions On 13th May, 206, deNOVO Biolabs was on the ground at CSIR-Central Drug Research Institute (CDRI), Lucknow - one of…
Inside deNOVO Biolabs' COVID-Era Supply Mission In 2020, the global life sciences industry faced a supply chain crisis it had never rehearsed for. COVID-19 didn't just disrupt commercial operations -…
